GTC

Ghost Tree Capital Portfolio holdings

AUM $276M
1-Year Est. Return 49.13%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+49.13%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$287M
AUM Growth
-$23.7M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
78
New
Increased
Reduced
Closed

Top Buys

1
+$11.8M
2
+$7.12M
3
+$6.11M
4
CGON icon
CG Oncology
CGON
+$5.84M
5
CRBP icon
Corbus Pharmaceuticals
CRBP
+$5.34M

Top Sells

1
+$11.1M
2
+$9.11M
3
+$6.65M
4
TGTX icon
TG Therapeutics
TGTX
+$5.78M
5
INSM icon
Insmed
INSM
+$5.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMT icon
51
Sagimet Biosciences
SGMT
$177M
$770K 0.24%
225,000
ITCI
52
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$685K 0.21%
+10,000
MGNX icon
53
MacroGenics
MGNX
$108M
$638K 0.2%
+150,000
PMVP icon
54
PMV Pharmaceuticals
PMVP
$54.3M
$608K 0.19%
375,000
-300,000
PTCT icon
55
PTC Therapeutics
PTCT
$5.81B
$581K 0.18%
+19,000
RVNC
56
DELISTED
Revance Therapeutics, Inc.
RVNC
$578K 0.18%
225,000
-225,000
NTLA icon
57
Intellia Therapeutics
NTLA
$1.28B
$560K 0.18%
25,000
ANTX icon
58
AN2 Therapeutics
ANTX
$29M
$472K 0.15%
219,331
CTMX icon
59
CytomX Therapeutics
CTMX
$888M
$366K 0.11%
300,000
-300,000
GERN icon
60
Geron
GERN
$932M
– –
-800,000
GPCR icon
61
Structure Therapeutics
GPCR
$5.17B
– –
-75,000
KALV icon
62
KalVista Pharmaceuticals
KALV
$728M
– –
-200,000
LRMR icon
63
Larimar Therapeutics
LRMR
$255M
– –
-210,603
MDGL icon
64
Madrigal Pharmaceuticals
MDGL
$10.5B
– –
-6,500
NTRA icon
65
Natera
NTRA
$27.5B
– –
-25,000
PTGX icon
66
Protagonist Therapeutics
PTGX
$5.04B
– –
-75,000
QURE icon
67
uniQure
QURE
$1.53B
– –
-165,000
RARE icon
68
Ultragenyx Pharmaceutical
RARE
$2.3B
– –
-20,000
RAPT icon
69
RAPT Therapeutics
RAPT
$1.67B
– –
0
XBI icon
70
State Street SPDR S&P Biotech ETF
XBI
$8.41B
– –
0
DCPH
71
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
-176,513
MRNS
72
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
– –
-285,000
ALT icon
73
Altimmune
ALT
$616M
– –
-250,000
AQST icon
74
Aquestive Therapeutics
AQST
$468M
– –
-702,941
ATXS
75
DELISTED
Astria Therapeutics
ATXS
– –
-115,000
1 2
3
4